Genetic Testing in Patients with Non-Small Cell Lung Cancer Before or After Surgery
Studying the genes in a patient's tumor cells may help determine the best treatment for patients with certain genetic changes.
Lung Adenocarcinoma Lung Large Cell Carcinoma Resectable Lung Non-Small Cell Carcinoma Stage IB Lung Non-Small Cell Carcinoma AJCC v7 Stage IB Lung Squamous Cell Carcinoma AJCC v7 Stage II Lung Non-Small Cell Cancer AJCC v7 Stage II Lung Squamous Cell Carcinoma AJCC v7 Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 Stage IIA Lung Squamous Cell Carcinoma AJCC v7 Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 Stage IIB Lung Squamous Cell Carcinoma AJCC v7 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIA Lung Squamous Cell Carcinoma AJCC v7 Carcinoma Carcinoma, Squamous Cell Adenocarcinoma Adenocarcinoma of Lung Carcinoma, Non-Small-Cell Lung Carcinoma, Large Cell Gemcitabine Paclitaxel Cisplatin Carboplatin Pembrolizumab Nivolumab Erlotinib Hydrochloride Albumin-Bound Paclitaxel Pemetrexed Crizotinib Clinical Observation Cytology Specimen Collection Procedure Erlotinib Gemcitabine Hydrochloride Pemetrexed Disodium
Lead Scientists at UC Cancer
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- David R. Gandara (ucdavis)
Professor, Hematology and Oncology. Authored (or co-authored) 454 research publications.
- Karen G. Chee (ucsf)
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Study Type
- Last Updated